XML 39 R28.htm IDEA: XBRL DOCUMENT v3.20.2
The Company and Basis of Presentation (Details)
$ / shares in Units, $ in Thousands
2 Months Ended 12 Months Ended
Apr. 13, 2020
USD ($)
$ / shares
shares
Aug. 11, 2019
Jul. 24, 2019
Jun. 30, 2019
USD ($)
Dec. 31, 2018
USD ($)
Sep. 30, 2020
USD ($)
Dec. 31, 2019
USD ($)
Sale of Stock              
Cash           $ 12,353 $ 13,908
Accumulated deficit           $ (47,034) $ (36,866)
Reverse stock split, ratio   0.0001          
Series A Redeemable Convertible Preferred Stock              
Sale of Stock              
Net proceeds         $ 16,800    
Registered Offering              
Sale of Stock              
Issuance of common stock in connection with equity financing (in shares) | shares 750,000            
Offering shares (Per share) | $ / shares $ 10            
Gross proceeds $ 7,500            
Convertible notes              
Sale of Stock              
Net proceeds         $ 500    
Series B Redeemable Convertible Preferred Stock              
Sale of Stock              
Net proceeds       $ 24,200      
Merger Agreement with NeuroBo              
Sale of Stock              
Reverse stock split, ratio     1.1431        
Percentage of interest held by our exiting shareholders     96.20%